drugset
drugset / Trial / NCT01809340

The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression

NCT01809340 ↗

Phase 2 Terminated 29 enrolled Janssen Research & Development, LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess whether the antidepressant effect from intravenous (IV) ketamine treatment can be maintained by minocycline compared to placebo after IV ketamine treatment is stopped.

Timeline

Start
2013-06
Primary completion
2014-07
Completion
2014-07

Outcome

Outcome not reported

Stopped: “study team decision because of IP supply issue and necessary amendment to protocol”

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 100 mg Oral
Background Ketamine Small molecule 0.5 mg/kg Intravenous

Indications

depressive disorder